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Abstract 
Background: Hepatosplenic T cell lymphoma (HSTL) is a rare but very aggressive peripheral 
T cell lymphoma whose initial silent clinical presentation unfortunately delays the diagnosis 
and worsens the prognosis of patient survival. Efforts should be aimed at early recognition 
and treatment. Methods: We describe a case of a 62-year-old woman who presented at our 
clinic with a non-palpable purpuric eruption of the face. Investigations revealed thrombocy-
topenia with hepatosplenomegaly, which showed rapid progression together with accentua-
tion of the purpura. Two months later, a bone marrow biopsy revealed the diagnosis of a 
HSTL. Results: The patient received six cycles of CHOP chemotherapy (vincristine, cyclophos-
phamide, doxorubicin, methylprednisolone) followed by a well-tolerated autologous bone 
marrow graft. Normalization of the platelet count resulted in regression of the purpuric rash. 
Conclusion: To our knowledge, this is the first report of a facial thrombocytopenic purpura 
as the inaugural symptom of HSTL. It emphasizes the privileged position of the dermatolo-
gist for early recognition of potentially lethal HSTL. © 2014 S. Karger AG, Basel 
Introduction 
Hepatosplenic T cell lymphoma (HSTL) is a rare but very aggressive peripheral T cell 
lymphoma (PTCL) affecting preferentially young men [1]. Hepatosplenic lymphomas are 
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composed of neoplastic mature T cells characterized by CD2, CD3, CD7 and CD16 expression; 
CD4, CD5 and CD8 as well as B cell surface markers are usually not expressed. HSTLs mostly 
express the gamma/delta T cell receptor (TCR) (hence the previous designation as 
gamma/delta T cell lymphoma) although some HSTLs express the alpha/beta TCR. A clonal 
rearrangement of the TCR can usually be demonstrated. HSTLs infiltrate the sinusoid in the 
spleen, liver, and bone marrow and affected patients usually present with hepatospleno-
megaly without lymphadenopathy. They occasionally complain of fever, night sweat and 
weight loss. Despite usual response to a CHOP chemotherapy regimen (vincristine, 
cyclophosphamide, doxorubicin, methylprednisolone), relapses are very common and the 
median survival of patients with a diagnosis of HSTL is unfortunately less than 2 years [2]. 
Therefore, efforts should be aimed at early recognition, diagnosis and treatment for HSTL.  
Although thrombocytopenia is commonly reported as a main feature of HSTL [3, 4], few 
cases describe purpuric eruption as a presenting symptom [5, 6]. Here, we report a case of a 
HSTL revealed by a purpuric eruption initially localized to the face and neck, emphasizing 
the role of purpura as a possible alerting presenting symptom. 
Case Report 
A 62-year-old woman presented to our department with an asymptomatic cutaneous 
eruption of the face extending to the neck that had appeared 2 weeks earlier. She did not 
report any infectious symptoms in the past weeks. Fever, night sweats or weight loss were 
denied. There was neither anamnestical atopy nor known allergies. Medication was limited 
to estradiol (substitution therapy) and occasional ibuprofen intake. Physical examination 
revealed non-palpable petechial purpura distributed on the face and extending to the neck 
(fig. 1). Peripheral white blood cell count, repartition and hemoglobin concentration were in 
the normal range, while platelet count was decreased to 90 G/l. Coagulation tests (aPTT, 
prothrombin time, fibrinogen) showed no anomaly. Lactate dehydrogenase, aspartate 
aminotransferase, and alanine aminotransferase were slightly elevated (LDH 316 U/l, ASAT 
58 U/l, ALAT 52 U/l); alkaline phosphatase, gamma-glutamyl transferase, total bilirubin and 
serum creatinine concentrations were all within normal limits. Protein electrophoresis and 
immune subtraction allowed ruling out a monoclonal gammopathy. Erythrocyte sedimenta-
tion rate and serum complement concentrations were within normal limits; antinuclear 
antibodies, ANCAs (c-ANCA, p-ANCA and x-ANCA) as well as serologies for HIV, HBV, HCV, 
CMV, EBV and PVB19 were all negative. Histopathological examination of the purpuric 
macules showed extravasation of erythrocytes and a slight lymphohistiocytic perivascular 
inflammation in the superficial and mid dermis, without evidence of vasculitis (fig. 2). 
Amplification of the TCR in the skin biopsy showed no monoclonality. Direct immunofluo-
rescence was negative. Given the particular distribution of the purpura in the upper part of 
the body, a cervico-thoracoabdominal CT scan was performed, which allowed to rule out a 
compressive component on the venous flow. It showed a multinodular goiter as well as a 
slight splenomegaly (12 cm). At that time, the patient was released with a diagnosis of 
idiopathic thrombocytopenic purpura. 
Two months later, the patient complained of night sweats and the purpuric eruption had 
extended to the whole body (fig. 3). Physical examination revealed a hepatosplenomegaly 
without palpable adenopathy. Thrombocytopenia had progressed to 30 G/l, LDH was 921 
U/l, ALAT 179 U/l, ASAT 236 U/l, alkaline phosphatase 156 U/l, gamma-glutamyl transfer-
ase 96 U/l and total bilirubin was 31 μmol/l. Other laboratory examinations were within 
normal limits. A thoracoabdominal CT scan showed progression of the splenomegaly (from 
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12 to 16 cm). The examination of the bone marrow biopsy and aspirate showed an atypical 
lymphoid infiltrate composed of medium-sized cells with oval to irregular nuclei, moderately 
abundant cytoplasms, featuring a predominantly sinusoidal distribution. Immunophenotyp-
ing (immunohistochemistry and flow cytometry) revealed atypical lymphoid cells which 
were CD2+/CD3+/CD4–/CD5–/CD7–/CD8–/CD30– and focal expression of the T cell-
restricted intracellular antigen-1 (TIA1). T cells strongly expressed the gamma/delta TCR 
and were negative for TCR beta F1. A monoclonal rearrangement of the TCR-gamma gene 
was demonstrated by PCR. We retained a diagnosis of HSTL and CHOP chemotherapy was 
administered together with a prophylactic intrathecal mixed chemotherapy (cytarabine, 
methotrexate, hydrocortisone). After two courses of treatment, the patient reported a 
diminution of night sweats, although the thoracoabdominal CT scan showed no modification, 
in particular no change in hepato- and splenomegaly; clinically, the purpuric rash showed a 
dramatic regression paralleled by a normalization of the platelet count (platelet count 157 
G/l). After six courses of chemotherapy, as the infiltration of the bone marrow by neoplastic 
T cells persisted, the patient underwent a well-tolerated autologous bone marrow graft. Two 
months later, no recurrence of the purpura was observed. A close clinical, biological and 
radiological follow-up for early detection of a potential HSTL recurrence is currently ongoing 
at the oncological unit. 
Discussion 
In this case report, we reported for the first time a rare case of HSTL whose clinical 
presentation was a petechial non-palpable purpura of the face. Dyscrasia and vasculitis, two 
common causes of purpuric eruption were ruled out by laboratory findings as well as by 
histopathological and direct immunofluorescence exams. Blood cell count revealed 
thrombocytopenia. In our case, association of the purpura to the thrombocytopenia was 
supported by the progression of the cutaneous eruption, as the thrombocytopenia got worse. 
Despite the fact that thrombocytopenia has been reported in most HSTL cases [3, 4], the 
mechanisms implicated remain unclear. Commonly accepted explanations are bone marrow 
infiltration by lymphomatous T cells as well as marked splenomegaly often presented in 
HSTL, both were found in our patient. Accordingly, splenectomy was reported to be 
beneficial for patients with HSTL presenting with severe thrombocytopenia [4]. Cases in 
which thrombocytopenia was mediated through the production of antiplatelet antibodies 
were also reported [3, 5]. As gamma/delta T cells are found in increased numbers in several 
specific autoimmune conditions (e.g., celiac disease, rheumatoid arthritis, systemic lupus 
erythematosus, type I diabetes, multiples sclerosis), it is hypothesized that gamma/delta 
lymphomatous T cells could activate the B cell population and the Th1-driven antiplatelet 
antibody production [7]. 
Here, we described for the first time a non-palpable purpura developing in the context 
of HSTL and which was initially limited to the face and neck region. Purpuric eruptions 
usually develop in the lower extremities, where a higher hydrostatic pressure is found. The 
atypical presentation of the purpura in the face and neck suggests additional specific 
contributing factors. A continuous or intermittent increase of the hydrostatic pressure in the 
face and neck vasculature could represent a possible explanation. Based on the cervico-
thoracoabdominal CT, radiologists ruled out any compression of the venous outflow from 
the face and neck area, in particular by the described multinodular goiter. Furthermore, the 
patient confidently and repeatedly denied either Valsalva-like spikes (repetitive coughing, 
vomiting or obstipation) or regular exercise [8]. Periorbital purpura has been associated 
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with AL type amyloidosis [9], although rather presenting as large purpuric macules 
(ecchymosis). However, in our case histopathological analysis revealed no sign of amyloido-
sis. Primary cutaneous gamma/delta lymphoma may also occur in the skin [10], and 
purpuric lesions may result from intradermal infiltration by lymphoma T cells. These T cells 
may directly trigger vascular destruction via the release of granzyme B [11]. Nevertheless, 
histopathology did not show evidence of neoplastic T cell infiltration in our patient, which 
was confirmed by molecular studies which failed to demonstrate T cell clonality in the skin. 
Finally, a purpuric eruption in the context of a viral activation seemed rather unlikely as 
serologies for HIV, HBV, HCV, CMV, EBV and PVB19 were all negative. 
Petechial purpura limited to sun-exposed areas has been previously described after 
solar exposure [12–14]. Histological analyses revealed erythrocyte extravasation, without 
signs of vasculitis but with mild lymphocytic perivascular infiltrates of the superficial and 
mid dermis, referred to as a ‘solar capillaritis’ in the literature [14]. Our case is suggestive of 
solar purpura as the purpura was initially limited to sun-exposed areas, with typical sparing 
of the submental V-shaped area (fig. 1). Furthermore, histological analysis confirmed the 
presence of a discrete perivascular lymphocytic infiltrate (fig. 2) reminiscent of solar 
capillaritis. The patient admitted regular solar exposure during the summer months, 
especially during the weeks preceding the cutaneous eruption. Interestingly, previous 
reports identified an association between solar purpura and additional predisposing factors, 
such as erythropoietic protoporphyria [15], high-dose aspirin intake [12] or thrombocyto-
penia [13]. Similarly, we believe that the particular presentation of the purpura to the face 
and neck in our patient is the result of the synergistic effect of HSTL-induced thrombocyto-
penia and superficial capillaritis induced by solar exposure.  
In conclusion, our case illustrates how thrombocytopenic purpura should be considered 
as a possible presenting feature of rare but devastating HSTL, allowing early recognition and 
rapid therapeutic intervention. An atypical facial presentation should prompt the clinician to 
look for additional contributing factors like local obstruction of the venous outflow, 
amyloidosis, neoplastic T cell infiltration of the skin or sun exposure. 
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Fig. 1. Clinical photographs of the patient at initial presentation. Lateral view showing a purpuric 
eruption of the face and neck, with sparing of the submental V-shaped area. 
 
 
 Case Rep Dermatol 2014;6:37–42 
DOI: 10.1159/000360126 
 
© 2014 S. Karger AG, Basel 
www.karger.com/cde 
Kuonen et al.: Purpura of the Face and Neck: An Atypical Clinical Presentation 
Revealing a Hepatosplenic T Cell Lymphoma 
 
 
42 
 
Fig. 2. A 5-mm punch biopsy specimen of the skin. Histopathological analysis showing mild perivascular 
lymphocytic infiltrates of the superficial dermis and erythrocyte extravasation. a HE, original magnifica-
tion ×100; b HE, original magnification ×400. 
 
 
 
Fig. 3. Photographs of the clinical evolution 2 months after the initial presentation. The clinical 
photographs show an intensification of the purpuric eruption of the face (a) as well as an extension of the 
purpura to the upper chest (b) and legs (c). 
 
